Intro to Cancer Biology Flashcards

1
Q

What are the Hallmarks of Cancer?

A

The list of the distinctive features shared by cancers, as found in Hanahan and Weinberg (2011), describes all the activities cancer cells must be doing in order to survive.

  • Sustaining Proliferative Signalling
  • Evading Growth Suppressors
  • Resisting Cell Death
  • Enabling Replicative Immortality
  • Deregulating Cellular Energetics
  • Promoting Genomic Instability & Mutation
  • Tumour Promoting Inflammation
  • Avoiding Immune Destruction
  • Inducing Angiogenesis
  • Invasion and Metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is the cell cycle normally regulated?

A

In normal cells, entry into the cell cycle is tightly controlled by a vast array of factors that opposingly inhibit and promote G1 entry. These allow for tight regulation that can respond to a huge variety of stimuli, also producing ‘checkpoints’ or ‘restriction points’ to prevent unnecessary growth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is the cell cycle deregulated in cancer cells?

A

Sustaining Proliferative Signalling & Evading Growth Suppressors

In cancer cells the growth factors (mitogens) are highly stimulated and the division cycle inhibitors are highly repressed. However cancer cells can become so deregulated that they will enter into the cell cycle even without strong activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is apoptosis regulated in normal and cancerous cells?

A

Under normal circumstances, apoptosis is controlled by the balance of pro-survival and pro-apoptotic signalling factors (extrinsic pathway), as well as happening in response to cellular or genomic damage/stress (intrinsic pathway).

The pro-apoptosis mechanisms are can be attenuated in cancer cells, particularly in tumours that progress to states of high-grade malignancy and therapy resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What occurs during apoptosis?

A

Apoptosis of a cell is a highly controlled process that involves cell shrinkage and condensation due to breakdown of the cytoskeleton.

Subsequent nuclear collapse leads to membrane blebbing and eventual splitting of the cell into large vesicles called apoptotic bodies that are then phagocytosed by immune cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the normal and cancerous regulation of replicative immortality.

A

Most cell lineages in the body can only divide a limited number of times (around 30-60) before they enter replicative senescence (i.e. irreversible growth arrest). This is accompanied by telomere shortening, which is thought to be responsible for entry into this state as the decay of the telomeres removes their protection of the ends of the chromosomes, leaving them vulnerable to end-to-end fusions.

In a high proportion of cancer cells however, the telomeres are more actively maintained by telomerase, enabling replicative immortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is angiogenesis a hallmark?

A

Due to their fast growth, large size and high metabolic rate, tumours require a strong supply of oxygen and nutrients as well as efficient disposal of toxic wastes. To provide this they recruit tumour associated neovasculature through the process of angiogenesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is metastasis?

A

The most life-threatening part of cancer, this is predicated upon the ability of the tumour cells to break away and travel to a new location to form another tumour, a process that happens in three discrete stages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the three stages of metastasis?

A

• Invasion
This is the process through which the cancer cells are able to dissociate from the primary tumour and move through the surrounding stroma (supportive/connective tissue + vasculature)

• Intravasation
This is the entry of the tumour cell into the bloodstream or lymphatic system through interaction with the epithelium, allowing it to metastasise – be swept away to another part of the body.

• Extravasation
The exit of the tumour cell from the haematogenous or lymphatic systems, allowing it to settle in the parenchyma (i.e. the functional tissue of an organ – non-connective or supportive).
The tumour cell then forms small nodules of cancer cells called micrometastasic lesions that grow into macroscopic tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are oncogenes?

A

Oncogenes are genes that, when mutated to produce a gain/increase of function, promote the formation of tumours. Hence the oncogene products – oncoproteins – are responsible for promoting proliferation, growth and survival etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What common trait is often shared by oncogenes?

A

These mutations are typically dominant alleles, as being gain of function mutations the incorrect oncoproteins is inevitably expressed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are tumour supressor genes?

A

Tumour suppressor genes, also called anti-oncogenes, are genes that, when mutated to cause a loss/reduction of function, lead to increased cancerogenesis. Hence they are genes whose products normally supress cancer trends such as proliferation growth and survival.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What common trait is often shared by tumour supressor genes?

A

These mutations are typically recessive, as if only one allele possesses the mutation the other is likely to be able to compensate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How often are oncogenic mutations heritable?

A

Around 90% of cancerogenic mutations (AKA Driver Mutations) are somatic, with only a small proportion being inherited through the germ-line. However, inherited mutations such as the BRCA1 gene can greatly increase the individual’s predisposition towards cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are cancer genome projects?

A

Cancer Genome Projects are using high-throughput mutation screening studies to identify sequence variants, somatic mutations and now epigenotypes involved in cancer. In order to be specific to humans this uses human cancer cell lines and, increasingly, human tumour tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How many genes have so far been implicated in cancer? What does this show?

A

So far around 500 genes have been implicated in cancer, with varying levels of effect. Some are frequently altered in many cancer types while others are more specific.

These findings serve to emphasise the complexity of the genetics of cancerogenesis and the importance of systems approaches to cancer, as well as revealing the diversity of the genetic changes involved and the mechanisms of cancer cell acquisition of drug resistance.

17
Q

What is a complex adaptive system?

A

‘Complex Adaptive System’ is a descriptive term used in many scientific and engineering fields to describe a system comprising a macroscopic collection formed of similar and partially connected micro-structures that co-operate to produce adaptability in order to survive a changing environment.

18
Q

What criteria are used to define a complex adaptive system?

A
  • Composed of many elements (and connected sub-systems)
  • The whole is greater than the sum of its parts
  • Self-organising
  • Co-evolves with the environment
  • Robust (redundant)
  • Demonstrates emerging properties (unpredictable)
  • Responds to feedback
  • Operates far from equilibrium (open system)
  • Operates by selecting one of a number of choices
  • System learns over time, creating new solutions
19
Q

What is oncogene addiction?

A

Some driver mutations make the cancer cells they create dependent upon their action for survival, a phenomenon termed oncogene addiction.

20
Q

How do cells become addicted to oncogenes?

A

The wildtype version of the regulatory node that is the oncogene is a signal-dependent part of the cell regulatory network, with a limited number of links to it.

However, in oncogene form it becomes constitutively expressed and causes it to rearrange the system as it affects many new parts of the system. The cell adapts to this until it is totally dependent upon the oncogene.

21
Q

How is oncogene addiction both a strength and weakness of cancer cells?

A

This is part of why cancer can be categorised as a complex adaptive system, its ability to adapt protects the cancer cells, making them difficult to kill. However, the dependence is also something that can be exploited in order to kill the tumour cells.

22
Q

What is BRAF mutant melanoma?

A

This is a variety of skin cancer caused by mutation of the BRAF oncogene.

23
Q

How was BRAF mutant melanoma treated? How effective was this?

A

Because this leads to oncogene addiction, a BRAF inhibitor called PLX4032 was used as a treatment.

At this first this seemed highly effective, as inhibiting the node upon which the cancer cells were addicted to killed them. However, the patient later relapsed. This was a result of the adaptive nature of cancer – the drug exerted a selection pressure upon the cancer cells forcing them to adapt until they were no longer addicted to the target oncogene.

24
Q

What is the general pipeline of cancer treatment?

A
  • Avoid Risk
  • Identify those at risk and screen them
  • Diagnose as early as possible
  • Establish extent of spread
  • Establish Prognosis
  • Select treatment
  • Analyse effect of treatment and adjust accordingly
  • Monitor homeostasis and adapt management
25
Q

What are the modifiable cancer risk factors, and how important are they?

A

Around 30-40% of cancer deaths can be directly attributed to behavioural and dietary risks, such as:
• Smoking
o 22% of global cancer deaths
o 71% of global lung cancer deaths

  • Alcohol
  • Infections
  • Obesity
  • Radiation (Sun based and medical scanning)
  • Air pollution/other environmental factors

However, some recent studies (Wu et al, 2015) estimate a much higher contribution of extrinsic risk factors to cancer development, with intrinsic risk factors providing only 10-30% of lifetime risk. This has been hailed by some as proof against the idea that cancer is often the result of bad luck.

26
Q

What are the various treatment options for cancer? Give examples

A

• Surgery
o Tumour removal

  • Radiotherapy
  • Chemotherapy

• Hormonal therapy
o Eg Tamoxifen, Letrozole

• Cytokine therapy
o Eg Interleukin-2 therapy

• Immunotherapy
o Eg rituximab, cancer vaccines

• Targeted therapy
o Personalised treatment based on genetic profile (eg BRAF treatment above)
o Utilises strategic combinations of drugs/therapies
o Eg Herceptin, Cetuximab, Avastin, Erlotinib, Imatinib

27
Q

What is personalised therapy?

A

Personalised therapy is based upon extraction of the DNA from the tumour and profiling it for somatic mutations known to be linked to cancer. This allows the design of a treatment based on the ‘actionable’ mutation profile, allowing the driver mutations to be targeted specifically.

28
Q

What has enabled personalised cancer therapy to be realistic?

A

Due to the huge reduction in cost of genome sequencing – having far outstripped Moore’s law to the point of $1000 genomes, with $100 genomes expected by 2020 – personalised therapies are soon going to become a more widely available option.

29
Q

What could personalised therapy lead to in terms of classification?

A

Cancers have so far been categorised based upon their location and histology, but this would allow cancers to be grouped by the driver mutations that produced them.

30
Q

What is the main limitation of personalised therapy?

A

The biological understanding of the cancer regulatory networks and their relationship to the mutations. The connection between genotype and phenotype is, for now, often unclear as to which mutation causes which phenotype.

31
Q

What is a novel way of obtaining cancer cells for genomic evaluation?

A

Liquid Biopsies

32
Q

What are liquid biopsies? What is their dis/advantages?

A

Circulating tumour cells (CTCs) present during metastasis can be harvested from the blood, as can circulating ‘free DNA’ (denoted as ctDNA) that is released from tumours as its cells die and are replaced.

This allows for rapid and non-invasive analysis of the current state of the cancer genotype. However, the blood-brain barrier prevents this from being a useful technique for brain cancers.